Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001932320-23-000003
Filing Date
2023-08-28
Accepted
2023-08-28 16:10:55
Documents
1
Period of Report
2023-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1693253445.html 4  
1 FORM 4 wk-form4_1693253445.xml 4 3429
  Complete submission text file 0001932320-23-000003.txt   4758
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Munk Natalie (Reporting) CIK: 0001932320 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 231215665